Karp Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,651
Closed -$207K 133
2022
Q2
$207K Hold
4,651
0.04% 136
2022
Q1
$263K Hold
4,651
0.04% 117
2021
Q4
$241K Hold
4,651
0.03% 137
2021
Q3
$278K Hold
4,651
0.04% 148
2021
Q2
$289K Hold
4,651
0.04% 144
2021
Q1
$303K Hold
4,651
0.05% 112
2020
Q4
$306K Hold
4,651
0.06% 104
2020
Q3
$240K Hold
4,651
0.06% 83
2020
Q2
$229K Hold
4,651
0.06% 86
2020
Q1
$237K Hold
4,651
0.08% 83
2019
Q4
$256K Hold
4,651
0.07% 98
2019
Q3
$234K Hold
4,651
0.07% 99
2019
Q2
$234K Sell
4,651
-4,777
-51% -$232K 0.07% 98
2019
Q1
$438K Hold
9,428
0.16% 91
2018
Q4
$463K Hold
9,428
0.22% 80
2018
Q3
$585K Hold
9,428
0.2% 94
2018
Q2
$508K Hold
9,428
0.2% 93
2018
Q1
$429K Hold
9,428
0.17% 96
2017
Q4
$371K Hold
9,428
0.16% 103
2017
Q3
$348K Hold
9,428
0.16% 97
2017
Q2
$363K Buy
+9,428
New +$345K 0.18% 88

Other funds holding EHC

Karp Capital Management's EHC Position: Q3 2022 in Review

Karp Capital Management sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 4,651 shares — an estimated $207K sold.

Karp Capital Management first reported a position in EHC in Q2 2017 and held it in 21 quarters. The position peaked at $585K in Q3 2018. 347 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • Karp Capital Management reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
  • Karp Capital Management sold 4,651 Encompass Health shares in Q3 2022, an estimated $207K.
  • Karp Capital Management first reported a position in Encompass Health in Q2 2017 and held it in 21 quarters.
  • Karp Capital Management's Encompass Health position peaked at $585K in Q3 2018.
  • 347 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on Karp Capital Management's 13F filing for Q3 2022, filed 18 Oct 2022.